Seventeen year mortality in a cohort of patients attending opioid agonist treatment in Ireland. Commentary on ‘methadone-maintained patients in primary care have higher rates of chronic disease’ (O’Toole et al., European Journal of General Practice 2014;20:275–80)

Jan KlimasUniversity College Dublin, School of Medicine and Medical Science, Dublin, Ireland;British Columbia Centre for Excellence in HIV/AIDS, Urban Health Research Initiative, Vancouver, CanadaCorrespondence[email protected]

Anna KeaneUniversity College Dublin, School of Medicine and Medical Science, Dublin, Ireland;British Columbia Centre for Excellence in HIV/AIDS, Urban Health Research Initiative, Vancouver, Canada

Walter CullenUniversity College Dublin, School of Medicine and Medical Science, Dublin, Ireland

Fergus O'KellyRialto Medical Practice, Dublin, Ireland

Gerard BuryUniversity College Dublin, School of Medicine and Medical Science, Dublin, Ireland

References

O’Toole J, Hambly R, Cox A-M, O’Shea B, Darker C. Methadone-maintained patients in primary care have higher rates of chronic disease and multimorbidity, and use health services more intensively than matched controls. Eur J Gen Pract. 2014;20; 4:275–280.
PubMed Web of Science ®Google Scholar
Cullen W, O’Brien S, O’Carroll A, O’Kelly FD, Bury G. Chronic illness and multimorbidity among problem drug users: A comparative cross sectional pilot study in primary care. BMC Fam Pract. 2009;10:25.
PubMed Web of Science ®Google Scholar
Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Dat Syst Rev. 2014;2:CD002207.
PubMed Web of Science ®Google Scholar
Bauer SM, Loipl R, Jagsch R, et al. Mortality in opioid-maintained patients after release from an addiction clinic. Eur Addict Res. 2008;14:82–91.
PubMed Web of Science ®Google Scholar
Langton D, Hickey A, Bury G, Smith M, O’Kelly F, Barry J, et al. Methadone maintenance in general practice: Impact on staff attitudes. Ir J Med Sci. 2000;169:133–136.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Seventeen year mortality in a cohort of patients attending opioid agonist treatment in Ireland. Commentary on ‘methadone-maintained patients in primary care have higher rates of chronic disease’ (O’Toole et al., European Journal of General Practice 2014;20:275–80)

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Seventeen year mortality in a cohort of patients attending opioid agonist treatment in Ireland. Commentary on ‘methadone-maintained patients in primary care have higher rates of chronic disease’ (O’Toole et al., European Journal of General Practice 2014;20:275–80)

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date